Skip to main content
BHR
NYSE Real Estate & Construction

Al Shams to Nominate Majority Slate of Five Independent Directors at Braemar's 2026 Annual Meeting

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: REIT Stocks · Real Estate
Sentiment info
Negative
Importance info
8
Price
$1.84
Mkt Cap
$126.37M
52W Low
$1.835
52W High
$3.19
52W Position info
0.3% above low
Off High info
42% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

BHR is trading near its 52-week low of $1.835 (0.3% above the low).

Summary

Al Shams Investments, Braemar's largest shareholder, will nominate a majority slate of five independent directors at the 2026 Annual Meeting, escalating its proxy fight against the incumbent board. On September 14, Al Shams named its five nominees: Jennifer Bitterman, Jonathan Klein, Anna Massion, Sir Michael Peat, and Wayne Walker.

Updated with an SEC DFAN14A filing · What changed

Updates

  1. · SEC DFAN14A — The five nominees hold no Braemar shares, and the nomination notice was nearly 900 pages.

    • Nominee Holdings — None of Jennifer L. Bitterman, Anna Massion, Jonathan Klein, Sir Michael Peat and Wayne R. Walker hold any shares of Common Stock of the Company.
    • Nomination Notice — The notice was nearly 900 pages and satisfied the onerous requirements of the Company’s governing documents.
    • Stock Performance — Since Braemar’s separation from Ashford Hospitality Trust in November 2013, the Company’s stock price has declined by more than 90%.
    • Advisor Fees — During this same period, substantial fees have been paid to the Company’s external advisor.
    All 4 details
    • None of Jennifer L. Bitterman, Anna Massion, Jonathan Klein, Sir Michael Peat and Wayne R. Walker hold any shares of Common Stock of the Company.
    • The notice was nearly 900 pages and satisfied the onerous requirements of the Company’s governing documents.
    • Since Braemar’s separation from Ashford Hospitality Trust in November 2013, the Company’s stock price has declined by more than 90%.
    • During this same period, substantial fees have been paid to the Company’s external advisor.
  2. · Dow Jones Newswires — Al Shams will nominate a full slate of five independent directors to oust chairman Monty Bennett and claw back his $480M termination payout, with the shareholder vote set for Nov. 13.


Key Events · Corporate Governance and Compliance · BHR

  • New · · SEC DFAN14A

    Nominee Details and Company Performance

    None of Jennifer L. Bitterman, Anna Massion, Jonathan Klein, Sir Michael Peat and Wayne R. Walker hold any shares of Common Stock of the Company. The notice was nearly 900 pages and satisfied the onerous requirements of the Company's governing documents. Since Braemar's separation from Ashford Hospitality Trust in November 2013, the Company's stock price has declined by more than 90%, during which substantial fees have been paid to the Company's external advisor.

  • Updated · · SEC DFAN14A

    Majority Slate Nomination Announced

    Al Shams Investments intends to nominate a complete slate of five independent directors sufficient to constitute a change in control of Braemar's Board at the 2026 Annual Meeting. On September 14, Al Shams named its five nominees: Jennifer Bitterman, Jonathan Klein, Anna Massion, Sir Michael Peat, and Wayne Walker.

  • Compressed Nomination Window

    Braemar announced its 2026 Annual Meeting date on September 4, 2026, with a September 14, 2026 shareholder director nomination deadline — a compressed window announced immediately before a holiday weekend.

  • Proxy Contest Escalation

    This filing marks a material escalation from Al Shams' prior minority-slate intentions to a full board takeover attempt, following months of accusations about governance failures and external management misalignment.

  • Ownership Stake

    Al Shams and Wafic Rida Said beneficially own 6,513,000 shares of Braemar common stock, representing 9.48% of the 68,679,318 shares outstanding as of August 4, 2026.


Analysis · BHR · Real Estate & Construction

Al Shams Investments, Braemar's largest shareholder with 6,513,000 shares (9.48% of outstanding), has escalated its proxy fight by announcing it will nominate a complete slate of five independent directors — enough to constitute a change in control of the Board. On September 14, Al Shams named its five nominees: Jennifer Bitterman, Jonathan Klein, Anna Massion, Sir Michael Peat, and Wayne Walker. None of the nominees hold any shares of Braemar common stock. The notice was nearly 900 pages and satisfied the onerous requirements of the Company's governing documents. Since Braemar's separation from Ashford Hospitality Trust in November 2013, the Company's stock price has declined by more than 90%, during which substantial fees have been paid to the Company's external advisor. This comes after Braemar announced its 2026 Annual Meeting date on September 4 with a September 14 nomination deadline, a compressed window announced immediately before a holiday weekend. Al Shams characterizes the timing as a governance maneuver designed to keep shareholders off guard, but states it is fully prepared and will submit nominations in compliance. The proxy contest has been ongoing since June 2026, with Al Shams previously accusing the board of governance failures and external management misalignment. This latest move raises the stakes from a minority slate to a full board takeover attempt, directly challenging the incumbent board's control.

How filings like this one have moved

In the 30 days to Oct 19, 2026, 37.9% of the 895 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BHR was trading at $1.84 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $126.4M. The 52-week trading range was $1.84 to $3.19. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BHR - Latest Insights

BHR
Oct 14, 2026, 3:39 PM EDT
Filing Type: PREC14A
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $1.43 info
Change: +$0.125 (+10%) info
Market Cap: $98.211M info
BHR
Oct 08, 2026, 4:51 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.44
Real-time Price: $1.43 info
Change: -$0.011 (-0.76%) info
Market Cap: $98.211M info
BHR
Oct 08, 2026, 4:28 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1.53
Real-time Price: $1.43 info
Change: -$0.100 (-7%) info
Market Cap: $98.211M info
BHR
Oct 08, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $1.43 info
Change: -$0.060 (-4%) info
Market Cap: $98.211M info
BHR
Oct 08, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $1.43 info
Change: -$0.060 (-4%) info
Market Cap: $98.211M info